CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Bionic Pancreas +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02105324
NCT02105324N/ACompleted

The Summer Camp Study 2: Outpatient Automated Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas in a Pediatric Population Ages 6-11 at the Clara Barton Diabetes Camps

Massachusetts General Hospital·interventional·Posted Apr 7, 2014·Updated Oct 20, 2017

In Brief

A clinical study evaluating Bionic Pancreas and Usual Care for Type 1 Diabetes. Completed, enrolled 19 participants across 1 site.

Detailed Summary

This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon can improve glycemic control vs. usual care for young people with type 1 diabetes ages 6-11 years old in a diabetes camp environment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsBoston University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 7, 2014
Enrollment StartJun 1, 2014
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.2 years ago

Interventions

Bionic Pancreasdevice

Automated blood glucose control via a closed-loop bionic pancreas device.

Usual Careother

As a comparator control, usual diabetes camp care with the participant's own insulin pump.